ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shanghai Bio-Heart Biological Technology Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 186.07% and Operating profit at 22.67% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -203.01
2
Flat results in Dec 25
- INTEREST(HY) At HKD 2.29 MM has Grown at 5,054.16%
- RAW MATERIAL COST(Y) Grown by 866% (YoY)
- DEBT-EQUITY RATIO (HY) Highest at -16.52 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 45.85%, its profits have risen by 25.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Bio-Heart Biological Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Bio-Heart Biological Technology Co., Ltd.
45.85%
0.79
96.59%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
186.07%
EBIT Growth (5y)
22.67%
EBIT to Interest (avg)
-203.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.33
EV to EBIT
-18.24
EV to EBITDA
-23.47
EV to Capital Employed
2.96
EV to Sales
46.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.21%
ROE (Latest)
-18.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(HY)
Higher at HKD 26.35 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 4.04 times
NET PROFIT(Q)
Highest at HKD -26.92 MM
-7What is not working for the Company
INTEREST(HY)
At HKD 2.29 MM has Grown at 5,054.16%
RAW MATERIAL COST(Y)
Grown by 866% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at -16.52 %
Here's what is working for Shanghai Bio-Heart Biological Technology Co., Ltd.
Net Sales
Higher at HKD 26.35 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (HKD MM)
Net Profit
Highest at HKD -26.92 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Net Profit
At HKD -26.92 MM has Grown at 60.05%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Debtors Turnover Ratio
Highest at 4.04 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at HKD 11.39 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 11.39 MM has Grown at 36.46%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Shanghai Bio-Heart Biological Technology Co., Ltd.
Interest
At HKD 2.29 MM has Grown at 5,054.16%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Debt-Equity Ratio
Highest at -16.52 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 866% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
